Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Sponsored Content: The Interpod Keystone for measuring supination resistance. Read about it here for more.
    Dismiss Notice
  2. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

The Use of a Collagen Bilayer Matrix (Omnigraft) and Risk Factors for Amputation

Discussion in 'Diabetic Foot & Wound Management' started by NewsBot, Oct 13, 2010.

  1. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1

    Members do not see these Ads. Sign Up.
    Functional Limb Salvage in the Diabetic Patient: The Use of a Collagen Bilayer Matrix and Risk Factors for Amputation.
    Iorio ML, Goldstein J, Adams M, Steinberg J, Attinger C.
    Plast Reconstr Surg. 2010 Oct 8. [Epub ahead of print]
     
  2. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Re: The Use of a Collagen Bilayer Matrix and Risk Factors for Amputation

    Ease of Use, Safety, and Efficacy of Integra Bilayer Wound Matrix in the Treatment of Diabetic Foot Ulcers in an Outpatient Clinical Setting
    A Prospective Pilot Study

    Min Yao, Khaled Attalla, Yanhan Ren, Michael A. French, Vickie R. Driver
    J Am Podiatr Med Assoc 103(4): 274–280, 2013
     
  3. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Re: The Use of a Collagen Bilayer Matrix and Risk Factors for Amputation

    A Clinical Trial of Integra? Template for Diabetic Foot Ulcer Treatment.
    Driver VR, Lavery LA, Reyzelman AM, Dutra TG, Dove CR, Kotsis SV, Myra Kim H, Chung KC
    Wound Repair Regen. 2015 Aug 22. doi: 10.1111/wrr.12357.
     
  4. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Re: The Use of a Collagen Bilayer Matrix and Risk Factors for Amputation

    FDA News Release
    FDA approves Integra Omnigraft Dermal Regeneration Matrix to treat diabetic foot ulcers
    January 7, 2016
     
  5. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    Integra LifeSciences Announces that Omnigraft Dermal Regeneration Matrix was Recognized as a Top Ten Innovation by Podiatry Today
     
Loading...

Share This Page